ZBH
HealthcareZimmer Biomet Holdings, Inc.
$92.65
+$2.63 (+2.92%)
Jan 5, 2026
Price History (1Y)
Analysis
Zimmer Biomet Holdings, Inc. is a leading company in the healthcare sector, specializing in medical devices. With a market capitalization of $18.36B and annual revenues of $8.01B, it operates on a large scale with approximately 17,000 employees. The company is part of the medical devices industry. The company's financial health indicates profitability, as evidenced by gross margin, operating margin, and profit margin rates of 71.6%, 17.0%, and 10.1% respectively. Returns on equity (ROE) and assets (ROA) stand at 6.4% and 4.3%. The balance sheet displays a significant debt burden with $8.24B in liabilities, but also substantial cash reserves of $1.31B. The current ratio is 2.43. The company's valuation metrics show a price-to-earnings (P/E) ratio of 22.33, which is higher than its forward P/E of 10.91. Revenue growth has been steady at 9.7% year-over-year, while earnings growth has experienced a decline of 5.7%. The dividend yield is notable at 107.0%, with a payout ratio of 23.8%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also develops surgical robot to enable placement of patient optimized orthopedic implants in the United States. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Visit website →Key Statistics
- Market Cap
- $18.36B
- P/E Ratio
- 22.33
- 52-Week High
- $114.44
- 52-Week Low
- $85.33
- Avg Volume
- 1.98M
- Beta
- 0.61
- Dividend Yield
- 107.00%
Company Info
- Industry
- Medical Devices
- Exchange
- NYQ
- Country
- United States
- Employees
- 17,000